The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Botti & Ferrari competitive analysis

Loading summary...

Explore patent oppositions filed by Botti & Ferrari against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3246047	Combination Drug	CHUGAI SEIYAKU KABUSHIKI KAISHA	Sep 24, 2025
EP4069254	Combination Decitabine And Cedazuridine Solid Oral Dosage Forms	OTSUKA PHARMACEUTICAL	Jun 11, 2025
EP3595667	Pharmaceutical Compositions Comprising A Jak Inhibitor	ALFASIGMA	Sep 17, 2024
EP3500241	Combination Therapy For Copd	CHIESI FARMACEUTICI	Jul 3, 2024
EP3634463	Improved Protocol For Treatment Of Lupus Nephritis	AURINIA PHARMACEUTICALS	Jun 26, 2024
EP3307271	Methods Of Using Pyruvate Kinase Activators	AGIOS PHARMACEUTICALS	Jun 11, 2024
EP3713919	Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide	AGIOS PHARMACEUTICALS	May 2, 2024
EP3844256	Mash Filter Membrane	HEINEKEN SUPPLY CHAIN	Mar 7, 2024
EP3474865	Process For Making Sugammadex	SYNTHON	Dec 1, 2022
EP2848602	Method For Producing Glycols From Oxirane Compound	SUMITOMO CHEMICAL	Sep 23, 2021

Discover the latest PTAB cases involving Botti & Ferrari, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Botti & Ferrari with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
BOTTI & FERRARI	14	-	-	-
ALFASIGMA	5	10	-	-
ALFA WASSERMANN	-	6	-	-
ARCHIMEDE SOLAR ENERGY	-	1	-	-